EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Established focal therapy—HIFU, IRE, or cryotherapy—where are we now?—a systematic review and meta-analysis

Kae Jack Tay iD, Khi Yung Fong, Armando Stabile iD, Jose Luis Dominguez-Escrig, Osamu Ukimura, Lara Rodriguez-Sanchez iD, Andreas Blana, Ezequiel Becher iD, M Pilar Laguna

Prostate Cancer and Prostatic Diseases · 2025-09 · 28 (3) · 693-706

DOI: 10.1038/s41391-024-00911-2 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Prostate Cancer and Prostatic Diseases, online erschienen am 28.10.2024. Verfasst von Kae Jack Tay und 8 weiteren Autor:innen. Beteiligte Einrichtung: Singapore General Hospital, Singapore; Duke-NUS Graduate Medical School, Singapore, Singapore. kaejack.tay@gmail.com. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Cryotherapy, High-Intensity Focused Ultrasound Ablation, Ultrasound, High-Intensity Focused, Transrectal. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOH | National Medical Research Council (NMRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Focal Therapy (FT) is a treatment option for the treatment of limited volume clinically significant prostate cancer (csPCa). We aim to systematically review outcomes of established FT modalities to assess the contemporary baseline and identify gaps in evidence that will aid in further trial and study design. METHODS: We conducted a systematic review and meta-analysis of all primary studies reporting outcomes of FT using cryotherapy, high-intensity focused ultrasound (HIFU), and irreversible electroporation (IRE). We described patient inclusion criteria, selection tools, treatment parameters, and surveillance protocols, and pooled overall survival (OS), cancer-specific survival (CSS), metastasis-free survival (MFS), biochemical progression (BP), biopsy, secondary treatment, sexual, and urinary function outcomes. Composite failure was defined as salvage whole gland ablation, radical treatment, hormonal therapy or transition to watchful waiting. SYNTHESIS: We identified 49 unique cohorts of men undergoing FT between 2008 and 2024 (21 cryotherapy, 20 HIFU, and 8 IRE). Median follow-up ranged from 6 to 63 months. Pooled OS was 98.0%, CSS 99.3%, and MFS 98.5%. Pooled BP was 9.4%/year. Biopsy was mandated post-FT within 24 months in 36/49 (73.5%) cohorts, with pooled csPCa (GG ≥ 2) rates of 22.2% overall, 8.9% infield, and 12.3% outfield. The pooled rate of secondary FT was 5.0%, radical treatment 10.5%, and composite failure 14.1%. Of 35 studies reporting sexual function, 45.7% reported a low, 48.6% moderate, and 5.7% severe impact. For 34 cohorts reporting urinary function, 97.1% reported a low impact. No differences were noted between cryotherapy, HIFU, or IRE in any of the outcomes. CONCLUSION: FT with cryotherapy, HIFU, and IRE is associated with good short-intermediate term oncological and functional outcomes. However, outcome reporting is heterogeneous and often incomplete. Long-term follow-up and standardized reporting are required to better define and report FT outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsCryotherapyHigh-Intensity Focused Ultrasound AblationUltrasound, High-Intensity Focused, TransrectalElectroporationHumansMaleTreatment Outcome

Autor:innen und Institutionen

  • Singapore General Hospital, Singapore; Duke-NUS Graduate Medical School, Singapore, Singapore. kaejack.tay@gmail.com.
  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Unit of Urology, Division of Oncology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
  • Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Urology Department, Institut Mutualiste Montsouris, Paris, France.

ORCID-Profile: Kae Jack Tay, Armando Stabile, Lara Rodriguez-Sanchez, Ezequiel Becher

Förderung

  • MOH | National Medical Research Council (NMRC)

Zitieren

APA

Tay, K. J., Fong, K. Y., Stabile, A., Dominguez-Escrig, J. L., Ukimura, O., Rodriguez-Sanchez, L., Blana, A., Becher, E., & Laguna, M. P. (2025). Established focal therapy—HIFU, IRE, or cryotherapy—where are we now?—a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 28(3), 693-706. https://doi.org/10.1038/s41391-024-00911-2

Vancouver

Tay KJ, Fong KY, Stabile A, Dominguez-Escrig JL, Ukimura O, Rodriguez-Sanchez L, et al. Established focal therapy—HIFU, IRE, or cryotherapy—where are we now?—a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 2025;28(3):693-706. doi:10.1038/s41391-024-00911-2

BibTeX
@article{Tay2025,
  author = {Tay, Kae Jack and Fong, Khi Yung and Stabile, Armando and Dominguez-Escrig, Jose Luis and Ukimura, Osamu and Rodriguez-Sanchez, Lara and Blana, Andreas and Becher, Ezequiel and Laguna, M Pilar},
  title = {Established focal therapy—HIFU, IRE, or cryotherapy—where are we now?—a systematic review and meta-analysis},
  journal = {Prostate Cancer and Prostatic Diseases},
  year = {2025},
  volume = {28},
  number = {3},
  pages = {693--706},
  doi = {10.1038/s41391-024-00911-2}
}
Kostenlos starten →